ARCHIVES

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

This article is from The Cancer Letter archive.

Vol. 09 No. 25 | June 24, 1983

Download PDF Visit The Full Archive

Related Articles

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998

NCI Asks $135 Billion for FY 1981, Tells How New Money Would Be Spent

June 1, 1979

Wyngaarden Opens Up Search for NCI Director, Invites Recommendations From Cancer Groups

September 30, 1988

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014